Indian Journal of Endocrinology and Metabolism

BRIEF COMMUNICATION
Year
: 2016  |  Volume : 20  |  Issue : 5  |  Page : 720--724

The inositols and polycystic ovary syndrome


Bharti Kalra1, Sanjay Kalra2, JB Sharma3 
1 Department of Obstetrics, Bharti Hospital, Karnal, Haryana, India
2 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
3 Department of Obstetrics, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital, Karnal, Haryana
India

This review describes the rationale, biochemical, and clinical data related to the use of inositols in polycystic ovary syndrome (PCOS). It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol (MDI), with randomized controlled trials conducted in women with PCOS, and utilizes these data to suggest pragmatic indications and methods for using MDI combination in PCOS. Rationally crafted inositol combinations have a potential role to play in maintaining metabolic, endocrine, and reproductive health in women with PCOS.


How to cite this article:
Kalra B, Kalra S, Sharma J B. The inositols and polycystic ovary syndrome.Indian J Endocr Metab 2016;20:720-724


How to cite this URL:
Kalra B, Kalra S, Sharma J B. The inositols and polycystic ovary syndrome. Indian J Endocr Metab [serial online] 2016 [cited 2020 Sep 28 ];20:720-724
Available from: http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=5;spage=720;epage=724;aulast=Kalra;type=0